A new era in hair loss management
We were founded with two core questions: Why, despite significant scientific advances, are only two treatments approved for hair loss? And can we deliver solutions that translate modern research directly into patient care?
80 million affected in US
80 years of research
2 outdated drugs approved
0 approvals since 1997
Why Now: Breakthroughts in Hair Loss Research
Since finasteride’s approval in 1997, advancements in hair loss science have surged. Yet, these insights remain underutilized in the treatments available to patients today — until today.
Solution: Hyper-focused teams and world-class domain expertise exclusively developing pharmacology targetting chronic and progressive hair loss.
With co-founders Dr. Nicholas Sadgrove and David Barreto personally affected by hair loss, our mission is clear: to improve outcomes for those facing chronic, progressive hair loss that is most common in hair transplant patients. After four years of refinement, systemK11 presents several firsts in hair loss management care such as targeting hair follicle glucose metabolism, mitochondrial function, and TGF-beta 1 using superior ingredient purity, bioavailability and standardisation.
Mission Driven, Interdiscipinary Teams
1
Mission
3
QA certifications
8+
Countries represented
20,000+
Hours of R&D